Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials

Young Ho Lee, Sang Cheol Bae

    Research output: Contribution to journalArticlepeer-review

    27 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

    Medicine & Life Sciences